40
Participants
Start Date
August 21, 2012
Primary Completion Date
November 3, 2014
Study Completion Date
July 3, 2019
Ipilimumab
Memorial Sloan Kettering Nassau, New York
Montefiore Medical Center, The Bronx
Magee-Womens Hospital Of Upmc, Pittsburgh
Duke University Medical Center, Durham
The Charlotte-Mecklenburg Hospital Authority, Charlotte
Winship Cancer Institute., Atlanta
AdventHealth Cancer Institute, Orlando
H. Lee Moffitt Cancer Center, Tampa
MetroHealth Medical Center, Cleveland
Indiana University Health Melvin And Bren Simon Cancer Center, Indianapolis
Dr. Sudarshan K. Sharma, Ltd., Hinsdale
Women'S Cancer Care, Covington
Peggy and Charles Stephenson Cancer Center, Oklahoma City
Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
Yale University School Of Medicine, New Haven
Georgia Regents University, Augusta
Dana Farber Cancer Institute., Boston
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY